Mqupin Liquid Wart Corn Remover

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of corns, calluses, flat warts, plantar warts, and common warts measuring less than 5 mm. It provides pain relief through the removal of corns and calluses.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be soaked in warm water for 5 minutes to soften the corn or wart. Following this, the brush must be installed into the bottle cap by pressing tightly and securing the cap. After drying the skin, the lid should be opened, and the liquid should be dipped using the brush. The liquid is then to be applied directly onto the wart or corn, allowing a mask to form before reapplying the liquid.

To alleviate pressure on the corn or callus, it is recommended to use cushions with a hole centered over the affected area. The treatment should be administered twice during the day and twice at night. This regimen should continue for a duration of 2 weeks, or until the skin has recovered its health. In cases where the corns or warts are particularly large, an extended treatment period may be necessary.

Contraindications

The product is contraindicated for use in the eye area.

Discontinue use if you are allergic to this product. If symptoms persist for more than 7 days or worsen, consult a physician. The product is also contraindicated for use during pregnancy or breastfeeding, and if you become pregnant or are planning to become pregnant while using this product.

While using the product, avoid contact with eyes and inhalation of vapors. In the event of contact with eyes, flush with water for 15 minutes.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the face and any healthy skin to prevent adverse reactions. In the event of contact with the eyes, it is essential to flush the area with water immediately. This product should be kept out of reach of children to prevent accidental ingestion or misuse. Additionally, it must not be applied to broken skin or the eye area.

Healthcare professionals should advise patients to discontinue use if they experience any allergic reactions to the product. If symptoms persist for more than 7 days or worsen, patients are encouraged to consult their physician for further evaluation. Special caution is warranted for pregnant or breastfeeding individuals; the product should not be used during these periods. Furthermore, if a patient becomes pregnant or is planning to become pregnant while using this product, they should cease use immediately and seek medical advice.

Side Effects

Patients using this product may experience a range of adverse reactions. It is important to note that this product is for external use only and should not come into contact with the face or healthy skin. In the event of contact with the eyes, patients should flush the area with water immediately. Additionally, the product should be kept out of reach of children and must not be applied to broken skin or the eye area.

Serious adverse reactions may occur in patients who are allergic to this product. If any allergic reactions are suspected, patients should discontinue use immediately. Furthermore, if symptoms persist for more than 7 days or worsen, it is advised that patients consult their physician.

Patients who are pregnant, breastfeeding, or planning to become pregnant while using this product should also stop use and seek medical advice. If discomfort persists, patients are encouraged to consult their doctor or podiatrist for further evaluation and management.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mqupin Liquid Wart Corn Remover (liquid wart corn remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. There are no specific age ranges, dosage differences, or study outcomes provided for pediatric use in the available data. Caution is advised when administering this medication to ensure safety and prevent accidental ingestion by children.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this product. There is a potential risk associated with the use of this product during pregnancy, and it is contraindicated for women who are pregnant or planning to become pregnant while using it. Healthcare professionals are advised to counsel patients on the importance of effective contraception during treatment and to discuss alternative options if pregnancy occurs or is planned.

Lactation

Lactating mothers are advised against the use of this product while breastfeeding. There is no available data on the excretion of the product in human milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the case effectively.

It is crucial to document all findings and interventions in the patient's medical record to ensure continuity of care and facilitate further management.

Nonclinical Toxicology

The use of this product during pregnancy or breastfeeding is not recommended. Women who are pregnant or planning to become pregnant while using this product should exercise caution due to potential teratogenic effects.

Individuals with known allergies to this product should avoid its use. In cases where symptoms persist for more than seven days or worsen, it is advised to consult a physician.

No relevant information is available regarding carcinogenicity, mutagenicity, or impairment of fertility. Additionally, there is no pertinent data related to animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion or misuse. Patients should be instructed not to apply the product to the area around the eyes, as this may lead to irritation or adverse effects.

Patients must be informed to discontinue use and consult a physician if they experience any allergic reactions to the product. Additionally, they should be advised to stop using the product if symptoms persist for more than seven days or worsen. It is important to discuss the implications of using this product during pregnancy or while breastfeeding; patients should be instructed to avoid use if they are pregnant, breastfeeding, or planning to become pregnant while using the product.

When using the product, patients should be cautioned to avoid contact with the eyes and to refrain from inhaling any vapors. In the event that the product comes into contact with the eyes, patients should flush the area with water for at least 15 minutes and seek medical attention if necessary.

Finally, healthcare providers should encourage patients to consult their doctor or podiatrist if discomfort persists, ensuring that they receive appropriate care and guidance.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored at a temperature range of 20° to 25°C (68° to 77°F). To maintain its integrity, the container must be closed tightly to prevent solidification. Additionally, it is recommended to store the product in a cool place to further ensure its stability and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended frequency of twice during the day and twice at night for a duration of two weeks, or until the skin recovers its health. In cases where corns or warts are particularly large, a longer treatment period may be necessary. Clinicians should advise patients to consult their doctor or podiatrist if discomfort persists during treatment.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Mqupin Liquid Wart Corn Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)